Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07747155
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Pyrotech Therapeutics, Inc. 40
Large-scale testing (Phase 3)Study completedNCT00783692
What this trial is testing

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Millennium Pharmaceuticals, Inc. 1,116
Testing effectiveness (Phase 2)Active Not RecruitingNCT05588843
What this trial is testing

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

Who this might be right for
Colitis Ulcerative
Sanofi 187
Early research (Phase 1)Ended earlyNCT03169894
What this trial is testing

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Avalo Therapeutics, Inc. 8
Large-scale testing (Phase 3)Study completedNCT02407236
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, UlcerativeInflammatory Bowel Diseases
Janssen Research & Development, LLC 961
Not applicableUnknownNCT06573944
What this trial is testing

IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study

Who this might be right for
Crohn's DiseaseUpadacitinibIntestinal Ultrasound+1 more
The Third Xiangya Hospital of Central South University 34
Large-scale testing (Phase 3)Study completedNCT03926130
What this trial is testing

Mirikizumab (LY3074828) in Participants With Crohn's Disease

Who this might be right for
Crohn's Disease
Eli Lilly and Company 1,158
Large-scale testing (Phase 3)Study completedNCT04706793
What this trial is testing

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Who this might be right for
Ulcerative Colitis
Pfizer 42
Testing effectiveness (Phase 2)Looking for participantsNCT06598943
What this trial is testing

Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 143
Not applicableEnded earlyNCT02092389
What this trial is testing

Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

Who this might be right for
Moderate to Severe Ulcerative Colitis
AbbVie 10
Early research (Phase 1)Not Yet RecruitingNCT07747480
What this trial is testing

A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 16
Large-scale testing (Phase 3)Ended earlyNCT00488774
What this trial is testing

An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 291
Large-scale testing (Phase 3)Study completedNCT00338650
What this trial is testing

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

Who this might be right for
Crohn's Disease
Abbott 1,000
Testing effectiveness (Phase 2)Study completedNCT00101946
What this trial is testing

Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 17
Large-scale testing (Phase 3)Looking for participantsNCT05837897
What this trial is testing

Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 408
Testing effectiveness (Phase 2)Looking for participantsNCT07507513
What this trial is testing

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Who this might be right for
Ulcerative Colitis (UC)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 288
Testing effectiveness (Phase 2)Active Not RecruitingNCT05731128
What this trial is testing

Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

Who this might be right for
Colitis Ulcerative
Sanofi 68
Post-approval studies (Phase 4)Looking for participantsNCT04999228
What this trial is testing

Top Down Versus Step up in Pediatric Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInfliximabChildren
Children's Hospital of Fudan University 40
Early research (Phase 1)Ended earlyNCT02864264
What this trial is testing

Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis

Who this might be right for
Healthy VolunteersUlcerative Colitis
Bristol-Myers Squibb 7
Post-approval studies (Phase 4)Not Yet RecruitingNCT07059130
What this trial is testing

Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis

Who this might be right for
Crohn Disease (CD)Crohns DiseaseUlcerative Colitis (UC)
Rubix LS 150
Next Page